Miromatrix Medical: Bioengineering Human Organs. Next Big Medical Breakthrough?
We believe that perfusion technology from Miromatrix differentiates from 3D bioprinting and genetically modified xenografts and has more advantages...
291 Views
SciClone Pharmaceuticals IPO Initiation: A Hard Sell
SciClone is pre-marketing a Hong Kong IPO to raise $500 million, according to press reports. Overall, on a fundamental basis, we are inclined to...
476 Views
China Biologic's Privatisation Redux
On Wednesday after market close, China Biologic Products (CBPO US) announced a surprising privatisation bid from a consortium for $120 per ADS. The...
486 Views
Para IV Winners and Losers - June 2018
This month’s Para IV developments suggest that there is likely to be benefit to Baxter International Inc (BAX US) on Premix Precedex (4mc/ml), Endo...
326 Views
China's Healthcare Reform Consolidates Drug Distribution and Cuts Manufacturer Margins
Rolling Out A “Two Invoices” System Nationwide:Although the announcement of a new policy to consolidate the distribution channels for both...
285 Views